Policy into practice
4-5 December 2024
QEII Centre London & online
Welcome to the BSAC Winter Conference 2024
If you missed the live event, you can still register to watch the recorded content from this two-day conference which was held in London and online.
This conference is RCPath CPD accredited (10 credits).
For all enquiries, please contract Esme Carruthers
Posters from this event are located here:
Programme
0830
Registration & coffee
0930
Welcome and opening remarks
Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC - View Bio
SESSION ONE: Infection - what's new?
Chair: Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC - View Bio
0935
Malaria patients with either hyper-parasitaemia or combination therapy treatment failure in the post-pandemic period: current challenges for the UK HSA Malaria Reference Laboratory
Professor Colin Sutherland, London School of Hygiene & Tropical Medicine - View Bio
0955
Prophylaxis as prevention of STIs - golden bullet or hostage to fortune?
Dr Helen Fifer, Consultant Microbiologist, UK Health Security Agency - View Bio
1015
Mpox
Dr Liz Whittaker, Imperial College London - View Bio
1035
Q&A
SESSION TWO: Invited Lecture
Chair: Dr Louise Sweeney, Manchester University NHS Foundation Trust - View Bio
1055
Infection: State of the Nation
Zubir Ahmed, MP for Glasgow South and PPS to Wes Streeting, Secretary of State for Health and Social Care
1120
Q&A
1130
REFRESHMENT BREAK EXHIBITION & POSTER VIEWING
SESSION THREE: Magic mushrooms! The challenge of managing invasive fungal infections
Chair: Professor Gavin Barlow, Professor of Infection, Hull York Medical School (HYMS), University of York - View Bio
1200
Clinical challenges in diagnosing and treating invasive fungal infections
Dr Neil Stone, Consultant in Infectious Diseases and Microbiology, University College London Hospitals and Associate Professor, UCL - View Bio
1220
The changing face of fungal diagnostics
Dr Rebecca Gorton, Health Services Laboratories
1240
Antifungal stewardship
Ms Laura Whitney, Regional Antimicrobial Stewardship Lead, NHSE - View Bio
1300
Q&A
1315
LUNCH BREAK EXHIBITION & POSTER VIEWING
SESSION FOUR: SUPPORTED SESSION
Chair: Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor, University Hospitals of Leicester NHS Trust - View Bio
Supported by: NAPP
1400
Managing invasive candidiasis in adults: challenges and considerations
Professor Tihana Bicanic, Professor of Infectious Diseases & Mycology, St George’s University of London - View Bio
SESSION FIVE: Realising the value of the specialist AMS Nursing Workforce
Chair: Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC - View Bio
1435
Introduction
Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC
1440
The UK AMR NAP – implications and opportunities for AMS in nursing
Dr Lisa Ritchie, National Deputy Director for Infection Prevention and Control, NHS England
1445
Role of the nurse in AMS - a view from Scotland
Mrs Jo McEwen, Lead Antimicrobial Stewardship Nurse, Ninewells Hospital
1455
Role of the nurse in AMS - a view from England
Mrs Laura Ahearn RGN, Advanced Clinical Practitioner, Northern Care Alliance NHS Foundation Trust
1505
Discussion
SESSION SIX: Invited lecture
Chair: Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and Past President, BSAC - View Bio
1520
Pull incentives - securing the pipeline, improving patient outcomes
Dr Christine Årdal, Senior Scientist, Norwegian Institute of Public Health - View Bio
1540
Q&A
1550
REFRESHMENT BREAK EXHIBITION & POSTER VIEWING
SESSION SEVEN: Invited papers supported by JAC and JAC-AMR
Chair: Dr Vicky Enne, Senior Research Fellow, King’s College London (KCL) & Guy’s and St. Thomas’s NHS Trust (GSTT) - View Bio
1620
Rapid respiratory microbiological POCTs and antibiotic use in primary care: the RAPID-TEST RCT
Dr Emily Brown, GP & NIHR Research Fellow, University of Bristol - View Bio
1635
Engaging health workers and the public to take action to tackle AMR: 10-years of the Antibiotic Guardian campaign
Professor Diane Ashiru-Oredope, UKHSA - View Bio
1650
Are proposed definitions of low-risk SAB clinically useful?
Dr Karla Berry, Internal Medical Trainee, NHS Borders
1705
Use of the novel antifungal rezafungin in outpatient parenteral antibiotic therapy: early experience from a single centre
Dr Harriet Davidson, Clinical Research Fellow, City St George’s University of London
1720
Q&A
1730
Day One closing remarks
Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC - View Bio
0830
Registration & coffee
SESSION EIGHT: GAMSAS - How was it for you? Experiences of accreditation from the front line
Chair: Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC - View Bio
0900
GAMSAS – The first two years
Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor, University Hospitals of Leicester NHS Trust - View Bio
0910
The large teaching hospital: Imperial College London
Professor Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust - View Bio
0925
Lagos University Teaching Hospital
Professor Oyinlola Oduyebo, University of Lagos
0935
Paediatrics: Great Ormond Street
Ms Orlagh McGarrity, Infection Pharmacist, Great Ormond Street Hospital for Children NHS Foundation Trust - View Bio
0950
Cancer Children's Hospital, Cairo
Mr Amr Kashef, Decision Support Senior Supervisor, Children's Cancer Hospital Egypt - View Bio
1000
Panel discussion
SESSION NINE: SUPPORTED SESSION
Supported by: Pfizer
1025
Aztreonam-avibactam and its potential position in the antimicrobial armamentarium
Dr Luke Moore, Infectious Disease Physician and Clinical Microbiologist, Chelsea & Westminster Hospital, London - View Bio
Dr Louise Sweeney, Consultant Microbiologist, Manchester University NHS Foundation Trust - View Bio
1055
REFRESHMENT BREAK EXHIBITION & POSTER VIEWING
SESSION TEN: What else could it be? Rare, unusual and non-infections
Chair: Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor, University Hospitals of Leicester NHS Trust - View Bio
1125
Paediatric case study: A captivating cavitating conundrum
Dr Gabriella Watson, Paediatric Infectious Diseases and Immunology Specialist Registrar, University Hospital Southampton - View Bio
1145
Is this an infection at all? Conditions that mimic infection
Dr Shrikant Ambalkar, Consultant Microbiologist, Sherwood Forest Hospitals NHS Trust - View Bio
1205
Therapeutic strategies for rare and imported pathogens
Dr Tommy Rampling, Consultant in infectious diseases & clinical virology, University College London Hospitals & UKHSA - View Bio
1225
Q&A
SESSION ELEVEN: SUPPORTED SESSION
Chair: Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC - View Bio
Supported by: Advanz Pharma
1245
An overview of cefepime enmetazobactam ▼: A treatment option for patients with gram negative Complicated urinary tract infections and Hospital-acquired pneumonia, including ventilator associated pneumonia
Dr Luke Moore, Infectious Disease Physician and Clinical Microbiologist, Chelsea & Westminster Hospital, London - View Bio
1315
LUNCH BREAK, EXHIBITION & POSTER VIEWING
SESSION TWELVE: Focus on neonatal infections
Chair: Dr Alicia Demirjian, UK Health Security Agency - View Bio
1400
Impact of NICE guidance on antibiotic use in premature neonates
Dr Mike Saunders, Specialty Registrar in Public Health, East of England, UKHSA - View Bio
1420
Neonatal bacterial sepsis - how do we improve the outlook?
Professor Eleanor Molloy, Professor and Chair of Paediatrics, Trinity College Dublin
1440
National incident response to Staphylococcus capitis in NICUs in England
Dr Alicia Demirjian, UK Health Security Agency - View Bio
1500
Q&A
SESSION THIRTEEN: Antimicrobial Susceptibility Testing - what next?
Chair: Dr Nick Brown, Consultant Medical Microbiologist, Cambridge University Hospitals NHS Trust - View Bio
1520
Where are we with EUCAST ?
Dr Robin Howe, Director of Infection Services, Public Health Wales Microbiology - View Bio
1540
Improving MIC measurements - are newly commercial available tests the answer?
Dr Rafael Cantón, Head of the Clinical Microbiology, Hospital Universitario Ramón y Cajal, Spain - View Bio
1600
Innovations in molecular testing in sepsis
Professor Ignacio Martin-Loeches, Trinity College Dublin & Consultant in Intensive Care Medicine, St James's Hospital
1620
Q&A
1635
Closing remarks
Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC - View Bio
Registration
Register here to access the recorded content.
For any questions regarding registration, please contact Esme Carruthers.
